Source:http://linkedlifedata.com/resource/pubmed/id/15077180
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
2004-4-29
|
pubmed:abstractText |
The ability of tumour cells to resist apoptosis-inducing signals by cytotoxic T cells may decide the success or failure of tumour elimination. An important effector of apoptosis is the CD95/CD95 ligand system (APO-1/Fas) that mediates perforin-independent cytotoxic T-cell killing of tumour cells. We propose a new strategy by which tumour cells can resist CD95-induced apoptosis. We identified matrix metalloproteinase-7, MMP-7 (Martilysin), as the first physiologically relevant protease that can specifically cleave CD95. MMP-7 is of unique importance because it is produced by the tumour cells themselves at early stages of tumour development. Microsequencing of the positions in CD95 cleaved by MMP-7 revealed two sites in the N-terminal extracellular domain of CD95, important for preligand assembly of CD95. MMP-7 cleavage of CD95 results in reduced CD95 surface expression and decreased CD95-mediated apoptosis sensitivity of tumour cells. Treatment of MMP-7-positive HT-29 tumour cells with MMP-7-antisense oligonucleotides led to an increase in CD95-mediated apoptosis sensitivity. Finally, specific cytotoxic T-cell killing was reduced in the presence of MMP-7. Thus, MMP-7 expression in tumour cells may contribute to an apoptosis-resistant phenotype, which ultimately promotes immune escape. This activity may account for the well-established role of MMP-7 in early tumour development.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0950-9232
|
pubmed:author |
pubmed-author:AllaVijayV,
pubmed-author:GallePeter RPR,
pubmed-author:GottfriedDanielaD,
pubmed-author:HeidHansH,
pubmed-author:KuballJürgenJ,
pubmed-author:StrandDennisD,
pubmed-author:StrandSusanneS,
pubmed-author:TheobaldMatthiasM,
pubmed-author:VollmerPetraP,
pubmed-author:van den AbeelenLotharL
|
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3732-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2004
|
pubmed:articleTitle |
Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells.
|
pubmed:affiliation |
I. Department of Internal Medicine, Johannes Gutenberg University, Obere Zahlbacherstr. 63, 55101 Mainz, Germany. sstrand@mail.uni-mainz.de
|
pubmed:publicationType |
Journal Article
|